Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: Int J Antimicrob Agents. 2018 Jan 31;51(3):479–483. doi: 10.1016/j.ijantimicag.2018.01.012

Table 1.

Ciprofloxacin and novobiocin MICs of qnr-positive and qnr-negative strains with the quinolone resistance determinants found.

Strains MIC (µg/ml) PMQR Topoisomerase mutationsa Other
PMQR
Reference


Ciprofloxacin Novobiocin GyrA ParC ParE
6–42 0.125 40 qnrB1 WTb WT WT - [12]
EC35 0.25 80 qnrB6 WT WT WT - [11]
UAB4 0.5 40 qnrA1 WT WT WT - [9]
6–75 0.5 80 qnrB19 WT WT WT - [12]
3–41 0.5 80 qnrB4 S83L WT WT - [12]
3–48 1 80 qnrS1 WT WT WT - [12]
6–74 2 80 qnrS1 S83L WT WT - [12]
4 128 160 qnrA1 S83L, D87N S80I WT aac(6’)-Ib-cr [10]
29 128 160 qnrA1 S83L, D87N S80I WT aac(6’)-Ib-cr [10]
7 256 80 qnrA1 S83L, D87N S80I, E84G WT - [10]
10 256 320 qnrA1 S83L, D87N S80I WT aac(6’)-Ib-cr [10]
12 128 320 qnrA1 S83L, D87N S80I WT aac(6’)-Ib-cr [10]
76 1024 40 qnrA1 S83L, D87N S80I S458A aac(6’)-Ib-cr, qepA1, oqxAB [10]
3–62 0.016 320 - WT WT WT - [12]
6–66 0.016 40 - WT WT WT - [12]
3–25 0.03 80 - WT WT WT - [12]
3–7 0.06 80 - WT WT WT - [12]
3–33 0.06 80 - WT WT WT - [12]
6–52 0.25 80 - S83L WT WT - [12]
4–76 0.5 80 - S83L WT WT - [12]
5–58 0.5 80 - S83L E84G WT - [12]
5–66 1 80 - S83L S80I WT - [12]
5–65 4 40 - S83L S80I WT - [12]
5–81 32 80 - S83L, D87N S80I WT - [12]
6–13 64 160 - S83L, D87N S80I S458A oqxAB [12]
5–33 64 160 - S83L, D87N S80I D420N - [12]
5–59 256 160 - S83L, D87N S80I S458T qepA1 [12]
a

Mutations in gyrB were not detected.

b

Wild type.